Healthcare stocks were edging higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.4% and the iShares Biotechnology ETF (IBB) advancing by 0.5%.
AstraZeneca (AZN) stock was up 0.8% after the company posted higher Q2 core earnings and revenue, and raised its interim dividend.
Ensign Group (ENSG) shares were up nearly 11% after the company reported higher Q2 adjusted earnings and revenue, and raised its 2026 outlook.
Argenx (ARGX) has agreed to buy Forte Biosciences (FBRX) for $77 per share in cash. Shares of Forte Biosciences were up more than 39% pre-bell.